Foundry ChEQ Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1CRM | SALESFORCE INC | Technology | $139.86B | 7.85% |
2FTNT | FORTINET INC | Technology | $118.40B | 6.64% |
3SNOW | SNOWFLAKE INC | Technology | $93.20B | 5.23% |
4MCO | MOODYS CORP | Financial Services | $89.25B | 5.01% |
5MMM | 3M CO | Industrials | $83.37B | 4.68% |
6CL | COLGATE PALMOLIVE CO | Consumer Defensive | $74.40B | 4.17% |
7LNG | CHENIERE ENERGY INC | Energy | $55.03B | 3.09% |
8CMG | CHIPOTLE MEXICAN GRILL INC | Consumer Cyclical | $44.18B | 2.48% |
9RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 2.22% |
10KR | KROGER CO | Consumer Defensive | $36.04B | 2.02% |
11WDAY | WORKDAY INC | Technology | $35.76B | 2.01% |
12TKO | TKO GROUP HOLDINGS INC | Communication Services | $35.38B | 1.99% |
13CNC | CENTENE CORP | Healthcare | $32.81B | 1.84% |
14EXPE | EXPEDIA GROUP INC | Industrials | $32.26B | 1.81% |
15ZTS | ZOETIS INC | Healthcare | $32.10B | 1.80% |
16LVS | LAS VEGAS SANDS CORP | Consumer Cyclical | $30.06B | 1.69% |
17TPR | TAPESTRY INC | Consumer Cyclical | $28.58B | 1.60% |
18ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 1.50% |
19MRNA | MODERNA INC | Healthcare | $24.53B | 1.38% |
20TEAM | ATLASSIAN CORP | Technology | $23.67B | 1.33% |
21UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 1.28% |
22RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 1.23% |
23GIS | GENERAL MILLS INC | Consumer Defensive | $20.26B | 1.14% |
24IP | INTERNATIONAL PAPER CO | Consumer Cyclical | $19.89B | 1.12% |
25LYB | LYONDELLBASELL INDUSTRIES NV | Basic Materials | $19.10B | 1.07% |
26FTV | FORTIVE CORP | Technology | $18.83B | 1.06% |
27DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 1.04% |
28CSL | CARLISLE COMPANIES INC | Basic Materials | $13.98B | 0.78% |
29EQH | EQUITABLE HOLDINGS INC | Financial Services | $13.79B | 0.77% |
30PINS | PINTEREST INC | Communication Services | $13.00B | 0.73% |
31MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.72% |
32DKNG | DRAFTKINGS INC | Consumer Cyclical | $12.37B | 0.69% |
33MGM | MGM RESORTS INTERNATIONAL | Consumer Cyclical | $11.80B | 0.66% |
34OC | OWENS CORNING | Basic Materials | $11.59B | 0.65% |
35CART | INSTACART (MAPLEBEAR INC) | Consumer Cyclical | $10.77B | 0.60% |
36WLK | WESTLAKE CORP | Basic Materials | $9.95B | 0.56% |
37PSKY | PARAMOUNT SKYDANCE CORP | Communication Services | $9.79B | 0.55% |
38MANH | MANHATTAN ASSOCIATES INC | Technology | $9.66B | 0.54% |
39IT | GARTNER INC | Technology | $9.39B | 0.53% |
40HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.52% |
41IONS | IONIS PHARMACEUTICALS INC | Healthcare | $8.99B | 0.50% |
42LB | LANDBRIDGE CO LLC | Energy | $8.89B | 0.50% |
43RAL | RALLIANT CORP | Technology | $7.85B | 0.44% |
44HXL | HEXCEL CORP | Industrials | $7.83B | 0.44% |
45MBLY | MOBILEYE GLOBAL INC | Consumer Cyclical | $7.76B | 0.44% |
46HIMS | HIMS & HERS HEALTH INC | Consumer Defensive | $7.60B | 0.43% |
47ACI | ALBERTSONS COMPANIES INC | Consumer Defensive | $7.47B | 0.42% |
48TAP | MOLSON COORS BEVERAGE CO | Consumer Defensive | $7.28B | 0.41% |
49PAYC | PAYCOM SOFTWARE INC | Technology | $7.05B | 0.40% |
50RIOT | RIOT PLATFORMS INC | Financial Services | $6.91B | 0.39% |
51FLR | FLUOR CORP | Industrials | $6.86B | 0.38% |
52CAG | CONAGRA BRANDS INC | Consumer Defensive | $6.83B | 0.38% |
53CROX | CROCS INC | Consumer Cyclical | $6.81B | 0.38% |
54CHE | CHEMED CORP | Healthcare | $6.77B | 0.38% |
55RRR | RED ROCK RESORTS INC | Consumer Cyclical | $6.76B | 0.38% |
56MORN | MORNINGSTAR INC | Financial Services | $6.56B | 0.37% |
57CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.34% |
58MIDD | MIDDLEBY CORP | Industrials | $6.02B | 0.34% |
59TFX | TELEFLEX INC | Healthcare | $5.96B | 0.33% |
60RIG | TRANSOCEAN LTD | Energy | $5.74B | 0.32% |
61WH | WYNDHAM HOTELS & RESORTS INC | Consumer Cyclical | $5.73B | 0.32% |
62MTN | VAIL RESORTS INC | Consumer Cyclical | $5.27B | 0.30% |
63IEP | ICAHN ENTERPRISES LP | Energy | $5.03B | 0.28% |
64CE | CELANESE CORP | Basic Materials | $5.01B | 0.28% |
65LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.25% |
66TENB | TENABLE HOLDINGS INC | Technology | $4.40B | 0.25% |
67CELC | CELCUITY INC | Healthcare | $4.31B | 0.24% |
68VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.24% |
69EXLS | EXLSERVICE HOLDINGS INC | Technology | $4.30B | 0.24% |
70GFF | GRIFFON CORP | Industrials | $4.20B | 0.24% |
71PII | POLARIS INC | Consumer Cyclical | $4.16B | 0.23% |
72MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.23% |
73HGV | HILTON GRAND VACATIONS INC | Consumer Cyclical | $3.98B | 0.22% |
74DK | DELEK US HOLDINGS INC | Energy | $3.88B | 0.22% |
75DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.21% |
76CCC | CCC INTELLIGENT SOLUTIONS HOLDINGS INC | Technology | $3.55B | 0.20% |
77AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.54B | 0.20% |
78LBTYA | LIBERTY GLOBAL LTD | Communication Services | $3.52B | 0.20% |
79VAC | MARRIOTT VACATIONS WORLDWIDE CORP | Consumer Cyclical | $3.43B | 0.19% |
80CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.19% |
81SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.18% |
82ACHC | ACADIA HEALTHCARE COMPANY INC | Healthcare | $3.17B | 0.18% |
83UAA | UNDER ARMOUR INC | Consumer Cyclical | $3.17B | 0.18% |
84CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.18% |
85PENG | PENGUIN SOLUTIONS INC | Technology | $3.10B | 0.17% |
86FSK | FS KKR CAPITAL CORP | Financial Services | $3.06B | 0.17% |
87EXPO | EXPONENT INC | Industrials | $3.05B | 0.17% |
88AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.17% |
89XRAY | DENTSPLY SIRONA INC | Healthcare | $2.81B | 0.16% |
90CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.16% |
91PENN | PENN ENTERTAINMENT INC | Consumer Cyclical | $2.75B | 0.15% |
92TNET | TRINET GROUP INC | Industrials | $2.74B | 0.15% |
93ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.15% |
94GRND | GRINDR INC | Technology | $2.71B | 0.15% |
95NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.15% |
96CC | CHEMOURS CO | Basic Materials | $2.63B | 0.15% |
97RUM | RUMBLE INC | Technology | $2.51B | 0.14% |
98TALO | TALOS ENERGY INC | Energy | $2.49B | 0.14% |
99ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.14% |
100AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.13% |
101BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.13% |
102INTA | INTAPP INC | Technology | $2.24B | 0.13% |
103NOG | NORTHERN OIL & GAS INC | Energy | $2.24B | 0.13% |
104SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.13% |
105AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.12% |
106AIN | ALBANY INTERNATIONAL CORP | Consumer Cyclical | $2.12B | 0.12% |
107GT | GOODYEAR TIRE & RUBBER CO | Consumer Cyclical | $2.10B | 0.12% |
108CDNA | CAREDX INC | Healthcare | $2.05B | 0.12% |
109NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.11% |
110SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.11% |
111JBLU | JETBLUE AIRWAYS CORP | Industrials | $2.02B | 0.11% |
112PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.11% |
113GNL | GLOBAL NET LEASE INC | Real Estate | $1.96B | 0.11% |
114NSP | INSPERITY INC | Industrials | $1.89B | 0.11% |
115CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.11% |
116WKC | WORLD KINECT CORP | Energy | $1.87B | 0.11% |
117MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.10% |
118SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.10% |
119MQ | MARQETA INC | Technology | $1.85B | 0.10% |
120FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.79B | 0.10% |
121BL | BLACKLINE INC | Technology | $1.78B | 0.10% |
122ASAN | ASANA INC | Technology | $1.77B | 0.10% |
123ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.10% |
124HROW | HARROW INC | Healthcare | $1.74B | 0.10% |
125BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.10% |
126ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.09% |
127FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.09% |
128VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.09% |
129NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.09% |
130ENOV | ENOVIS CORP | Industrials | $1.56B | 0.09% |
131CNXC | CONCENTRIX CORP | Technology | $1.49B | 0.08% |
132BLKB | BLACKBAUD INC | Technology | $1.49B | 0.08% |
133PRGO | PERRIGO CO PLC | Healthcare | $1.48B | 0.08% |
134LILA | LIBERTY LATIN AMERICA LTD | Communication Services | $1.48B | 0.08% |
135MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.08% |
136ALX | ALEXANDERS INC | Real Estate | $1.44B | 0.08% |
137ULCC | FRONTIER GROUP HOLDINGS INC | Industrials | $1.43B | 0.08% |
138ECVT | ECOVYST INC | Basic Materials | $1.41B | 0.08% |
139WBTN | WEBTOON ENTERTAINMENT INC | Technology | $1.41B | 0.08% |
140FMC | FMC CORP | Basic Materials | $1.40B | 0.08% |
141AI | C3AI INC | Technology | $1.37B | 0.08% |
142CXM | SPRINKLR INC | Technology | $1.37B | 0.08% |
143LZ | LEGALZOOMCOM INC | Industrials | $1.33B | 0.07% |
144HLIT | HARMONIC INC | Technology | $1.31B | 0.07% |
145XNCR | XENCOR INC | Healthcare | $1.30B | 0.07% |
146AMPL | AMPLITUDE INC | Technology | $1.27B | 0.07% |
147TDAY | USA TODAY CO INC | Consumer Cyclical | $1.25B | 0.07% |
148QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.07% |
149EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.06% |
150SVC | SERVICE PROPERTIES TRUST | Real Estate | $1.11B | 0.06% |
151PCT | PURECYCLE TECHNOLOGIES INC | Industrials | $1.09B | 0.06% |
152CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.06% |
153NMAX | NEWSMAX INC | Communication Services | $1.08B | 0.06% |
154AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.06% |
155PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.06% |
156EVC | ENTRAVISION COMMUNICATIONS CORP | Communication Services | $984M | 0.06% |
157SMPL | SIMPLY GOOD FOODS CO | Consumer Defensive | $980M | 0.05% |
158KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.05% |
159GO | GROCERY OUTLET HOLDING CORP | Consumer Defensive | $934M | 0.05% |
160TROX | TRONOX HOLDINGS PLC | Basic Materials | $932M | 0.05% |
161EIG | EMPLOYERS HOLDINGS INC | Financial Services | $918M | 0.05% |
162WRLD | WORLD ACCEPTANCE CORP | Financial Services | $891M | 0.05% |
163MAX | MEDIAALPHA INC | Communication Services | $880M | 0.05% |
164REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.05% |
165NX | QUANEX BUILDING PRODUCTS CORP | Basic Materials | $835M | 0.05% |
166FOXF | FOX FACTORY HOLDING CORP | Consumer Cyclical | $798M | 0.04% |
167CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.04% |
168IBTA | IBOTTA INC | Technology | $734M | 0.04% |
169CLYM | CLIMB BIO INC | Healthcare | $727M | 0.04% |
170CBLL | CERIBELL INC | Healthcare | $710M | 0.04% |
171SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.04% |
172PRAA | PRA GROUP INC | Financial Services | $691M | 0.04% |
173NXRT | NEXPOINT RESIDENTIAL TRUST INC | Real Estate | $678M | 0.04% |
174NMFC | NEW MOUNTAIN FINANCE CORP | Financial Services | $672M | 0.04% |
175CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.04% |
176HELE | HELEN OF TROY LTD | Consumer Defensive | $655M | 0.04% |
177EVH | EVOLENT HEALTH INC | Healthcare | $654M | 0.04% |
178MSBI | MIDLAND STATES BANCORP INC | Financial Services | $645M | 0.04% |
179NVRI | ENVIRI CORP | Industrials | $643M | 0.04% |
180RWT | REDWOOD TRUST INC | Real Estate | $641M | 0.04% |
181CWH | CAMPING WORLD HOLDINGS INC | Consumer Cyclical | $637M | 0.04% |
182KLC | KINDERCARE LEARNING COMPANIES INC | Consumer Defensive | $618M | 0.03% |
183TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.03% |
184NGNE | NEUROGENE INC | Healthcare | $590M | 0.03% |
185ALIT | ALIGHT INC | Technology | $584M | 0.03% |
186MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.03% |
187IIIV | I3 VERTICALS INC | Technology | $579M | 0.03% |
188RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.03% |
189EGY | VAALCO ENERGY INC | Energy | $553M | 0.03% |
190NPCE | NEUROPACE INC | Healthcare | $548M | 0.03% |
191YEXT | YEXT INC | Technology | $535M | 0.03% |
192TASK | TASKUS INC | Technology | $534M | 0.03% |
193KELYA | KELLY SERVICES INC | Industrials | $531M | 0.03% |
194ARVN | ARVINAS INC | Healthcare | $517M | 0.03% |
195DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $517M | 0.03% |
196RGNX | REGENXBIO INC | Healthcare | $511M | 0.03% |
197ADV | ADVANTAGE SOLUTIONS INC | Communication Services | $508M | 0.03% |
198NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.03% |
199NRC | NRC HEALTH | Healthcare | $491M | 0.03% |
200SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.03% |
201PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.03% |
202STRZ | STARZ ENTERTAINMENT CORP | Communication Services | $450M | 0.03% |
203FWRD | FORWARD AIR CORP | Industrials | $435M | 0.02% |
204CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.02% |
205ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.02% |
206OEC | ORION SA | Basic Materials | $386M | 0.02% |
207MGPI | MGP INGREDIENTS INC | Consumer Defensive | $382M | 0.02% |
208CVEO | CIVEO CORP | Industrials | $382M | 0.02% |
209UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.02% |
210ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.02% |
211PLAY | DAVE & BUSTER'S ENTERTAINMENT INC | Communication Services | $355M | 0.02% |
212SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.02% |
213VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.02% |
214FNKO | FUNKO INC | Consumer Cyclical | $326M | 0.02% |
215PESI | PERMA FIX ENVIRONMENTAL SERVICES INC | Industrials | $324M | 0.02% |
216ALDF | ALDEL FINANCIAL II INC | Industrials | $320M | 0.02% |
217JACS | JACKSON ACQUISITION CO II | Industrials | $317M | 0.02% |
218LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.02% |
219PAMT | PAMT CORP | Industrials | $311M | 0.02% |
220PSBD | PALMER SQUARE CAPITAL BDC INC | Financial Services | $306M | 0.02% |
221ALCO | ALICO INC | Consumer Defensive | $304M | 0.02% |
222OPTX | SYNTEC OPTICS HOLDINGS INC | Technology | $302M | 0.02% |
223TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.02% |
224SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.02% |
225TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.02% |
226HCKT | HACKETT GROUP INC | Technology | $261M | 0.01% |
227LMNR | LIMONEIRA CO | Consumer Defensive | $245M | 0.01% |
228ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.01% |
229GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.01% |
230SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.01% |
231FC | FRANKLIN COVEY CO | Industrials | $229M | 0.01% |
232ONEW | ONEWATER MARINE INC | Consumer Cyclical | $224M | 0.01% |
233KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
234BDSX | BIODESIX INC | Healthcare | $204M | 0.01% |
235FOCL | FOCAL INC | Healthcare | $204M | 0.01% |
236FORR | FORRESTER RESEARCH INC | Industrials | $200M | 0.01% |
237AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.01% |
238SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.01% |
239COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.01% |
240STRW | STRAWBERRY FIELDS REIT INC | Real Estate | $190M | 0.01% |
241ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
242NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.01% |
243MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.01% |
244AP | AMPCO PITTSBURGH CORP | Industrials | $156M | 0.01% |
245DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
246OCC | OPTICAL CABLE CORP | Technology | $130M | 0.01% |
247FIRY | FIRY INC | Technology | $130M | 0.01% |
248AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
249JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
250SAMG | SILVERCREST ASSET MANAGEMENT GROUP INC | Financial Services | $118M | 0.01% |
251STHO | STAR HOLDINGS | Real Estate | $114M | 0.01% |
252CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $103M | 0.01% |
253CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.01% |
254GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.00% |
255FVN | FUTURE VISION II ACQUISITION CORP | Industrials | $83M | 0.00% |
256AEYE | AUDIOEYE INC | Technology | $82M | 0.00% |
257BARK | BARK INC | Consumer Cyclical | $82M | 0.00% |
258WTG | WINTERGREEN ACQUISITION CORP | Industrials | $76M | 0.00% |
259GECC | GREAT ELM CAPITAL CORP | Financial Services | $74M | 0.00% |
260BGSF | BGSF INC | Industrials | $65M | 0.00% |
261EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
262MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.00% |
263EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
264TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.78T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 68% toward Growth. +17% unclassified (53 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 264 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual28.2%Margin-3.2%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 264 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 19.2% | 9.0% |
| 3 yearsp.a. | 19.7% | -9.4% |
| 5 yearsp.a. | 11.6% | -5.1% |
| 10 yearsp.a. | 14.5% | -2.6% |
| Since inceptionp.a. | 9.4% | 0.5% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 6.5% | 2.3% |
| 2025 | 29.8% | -0.6% |
| 2024 | 18.4% | -30.2% |
| 2023 | 19.9% | -16.4% |
| 2022 | -14.2% | 34.9% |
| 2021 | 10.4% | -8.7% |
| 2020 | 39.3% | -2.2% |
| 2019 | 36.5% | 10.1% |
| 2018 | -10.4% | -2.9% |
| 2017 | 16.5% | -5.1% |
| 2016 | 17.9% | 13.0% |
| 2015 | -0.3% | 0.6% |
| 2014 | 16.9% | 6.9% |
| 2013 | 37.4% | 8.3% |
| 2012 | 20.7% | -4.6% |
| 2011 | 6.7% | 7.4% |
| 2010 | 19.5% | -5.9% |
| 2009 | 29.5% | -19.6% |
| 2008 | -39.8% | 21.5% |
| 2007 | 9.4% | -5.9% |
| 2006 | 20.5% | 6.6% |
| 2005 | -1.4% | -8.3% |
| 2004 | 5.5% | -4.0% |
| 2003 | 39.8% | 1.0% |
| 2002 | -31.3% | 0.8% |
| 2001 | -5.9% | 35.6% |
| 2000 | 2.2% | 45.8% |
| 1999 | 13.5% | -27.8% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry ChEQ Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a ChEQ signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.